Evonik (Pharma)
Parsippany, NJ (US) · United States
Specialization: Functional Coatings & Drug Delivery
Key Differentiator
Part of Evonik Industries (€15.3B); dominates functional coating market with EUDRAGIT range; expanded lipid excipients for mRNA/LNP platforms (Jan 2025); integrated excipient + CDMO
Core Services
EUDRAGIT (enteric/sustained release coatings), RESOMER (biodegradable polymers for drug delivery), lipid excipients for LNP/mRNA, CDMO services for parenteral drug delivery
Capabilities
Market Intelligence
Parenteral excipients growing at 8.23% CAGR; plant-based excipients = 18.23% share (2024)
Similar Companies
AGC Biologics
Bothell, WA (US HQ); Boulder, CO; Longmont, CO ·
Proprietary CHEF1® expression system
ARSI Canada Inc.
Mississauga, ON (Unit 16, 6800 Kitimat Rd) · Custom synthesis, analytical development, drug development
Mississauga CRO
Actylis (Montreal Operations)
Quebec ·
Global API and excipient supplier with Canadian manufacturing
Ajinomoto Bio-Pharma Services
San Diego, CA; Oss, Netherlands ·
Proprietary AJICAP™ site-specific ADC bioconjugation technology
Need help finding the right outsourcing partner?
Try AI NavigatorCompany information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.